UA95602C2
(ru)
|
2004-12-30 |
2011-08-25 |
Берингер Ингельхейм Ветмедика, Инк. |
Иммуногенная композиция цвс2 и способы приготовления такой композиции
|
US7833707B2
(en)
|
2004-12-30 |
2010-11-16 |
Boehringer Ingelheim Vetmedica, Inc. |
Methods of overexpression and recovery of porcine circovirus type 2 ORF2
|
US7700285B1
(en)
|
2005-12-29 |
2010-04-20 |
Boehringer Ingelheim Vetmedica, Inc. |
PCV2 immunogenic compositions and methods of producing such compositions
|
US8703095B2
(en)
|
2005-07-07 |
2014-04-22 |
Sanofi Pasteur S.A. |
Immuno-adjuvant emulsion
|
BRPI0615862A2
(pt)
*
|
2005-09-09 |
2011-05-31 |
Intervet Int Bv |
vacina contra pcv-2, e, método para a manufatura de uma vacina
|
WO2007052056A1
(fr)
|
2005-11-04 |
2007-05-10 |
Novartis Vaccines And Diagnostics Srl |
Vaccins influenza avec adjuvant comprenant des agents d'induction de cytokines
|
US10842867B2
(en)
|
2005-11-04 |
2020-11-24 |
Seqirus UK Limited |
Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
|
AU2006310163B2
(en)
|
2005-11-04 |
2011-09-15 |
Seqirus UK Limited |
Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant
|
HUE029552T2
(en)
|
2005-12-29 |
2017-03-28 |
Boehringer Ingelheim Vetmedica Inc |
Use of PCV2 immunogenic composition to reduce clinical symptoms in piglets
|
ES2814473T3
(es)
|
2005-12-29 |
2021-03-29 |
Boehringer Ingelheim Animal Health Usa Inc |
Composiciones inmunogénicas de PCV2 multivalentes y métodos para producir dichas composiciones
|
FR2896162B1
(fr)
|
2006-01-13 |
2008-02-15 |
Sanofi Pasteur Sa |
Emulsion huile dans eau thermoreversible
|
JP2009528361A
(ja)
*
|
2006-03-03 |
2009-08-06 |
メリアル リミテッド |
マイコプラズマ・ハイオニューモニエワクチン
|
JP2009534303A
(ja)
|
2006-03-24 |
2009-09-24 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス ゲーエムベーハー アンド カンパニー カーゲー |
冷蔵しないインフルエンザワクチンの保存
|
GB0614460D0
(en)
|
2006-07-20 |
2006-08-30 |
Novartis Ag |
Vaccines
|
EP2497495B3
(fr)
|
2006-09-11 |
2021-02-17 |
Seqirus UK Limited |
Fabrication de vaccins contre la grippe sans utiliser d'oeufs
|
EP2099927A4
(fr)
*
|
2006-11-22 |
2010-05-05 |
Boehringer Ingelheim Vetmed |
Procedes de reduction des flambees des maladies associees au circovirus porcin
|
PL2121011T3
(pl)
|
2006-12-06 |
2014-10-31 |
Novartis Ag |
Szczepionki zawierające antygeny czterech szczepów wirusa grypy
|
EP2101815A4
(fr)
|
2006-12-11 |
2010-10-06 |
Boehringer Ingelheim Vetmed |
Procede efficace de traitement du circovirus porcin et des infections par lawsonia intracellularis
|
EP3466442A1
(fr)
|
2006-12-15 |
2019-04-10 |
Boehringer Ingelheim Vetmedica, Inc. |
Traitement des porcs mda positive avec l'antigène pcv2
|
EP1941903A1
(fr)
*
|
2007-01-03 |
2008-07-09 |
Boehringer Ingelheim Vetmedica Gmbh |
Prophylaxie et traitement du PRDC
|
EP1958644A1
(fr)
*
|
2007-02-13 |
2008-08-20 |
Boehringer Ingelheim Vetmedica Gmbh |
Prévention et traitement du PCVD subclinique
|
MY180465A
(en)
|
2007-04-06 |
2020-11-30 |
Takeda Vaccines Inc |
Methods and compositions for live attenuated viruses
|
ES2393162T3
(es)
|
2007-06-27 |
2012-12-19 |
Novartis Ag |
Vacunas antigripales con un contenido reducido de aditivos
|
US20090017064A1
(en)
*
|
2007-07-10 |
2009-01-15 |
Wyeth |
Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
US7829274B2
(en)
|
2007-09-04 |
2010-11-09 |
Boehringer Ingelheim Vetmedica, Inc. |
Reduction of concomitant infections in pigs by the use of PCV2 antigen
|
PT2200642E
(pt)
|
2007-10-19 |
2012-05-30 |
Novartis Ag |
Formulações de vacinas meningocócicas
|
GB0810305D0
(en)
|
2008-06-05 |
2008-07-09 |
Novartis Ag |
Influenza vaccination
|
LT2224951T
(lt)
*
|
2007-12-21 |
2020-01-10 |
Zoetis Services Llc |
Termiškai apdoroti bakterinai ir iš tokių termiškai apdorotų bakterinų paruoštos emulsinės vakcinos
|
KR20100103535A
(ko)
*
|
2007-12-31 |
2010-09-27 |
베링거잉겔하임베트메디카인코퍼레이티드 |
외래 아미노산 삽입물을 갖는 pcv2 orf2 바이러스 유사 입자
|
MX2010007815A
(es)
|
2008-01-23 |
2010-08-10 |
Boehringer Ingelheim Vetmed |
Composiciones inmunogenicas de mycoplasma hyopneumoniae contra pcv2 y metodos para producir composiciones de este tipo.
|
CA2718430A1
(fr)
|
2008-03-18 |
2009-09-24 |
Novartis Ag |
Ameliorations dans la preparation des antigenes pour le vaccin contre le virus de la grippe
|
CA2732035A1
(fr)
*
|
2008-07-30 |
2010-02-04 |
University Of Kentucky Research Foundation |
Modele de maladie equine pour maladie neurologique a virus herpetique et utilisations assiociees
|
WO2010032138A2
(fr)
|
2008-09-18 |
2010-03-25 |
Novartis Ag |
Combinaisons d’adjuvant de vaccin
|
WO2010063033A2
(fr)
|
2008-11-28 |
2010-06-03 |
Merial Limited |
Vaccin contre la grippe aviaire recombiné et ses utilisations
|
EP3173097A3
(fr)
|
2009-02-10 |
2017-07-12 |
Seqirus UK Limited |
Vaccins contre la grippe dotés de quantités réduites de squalène
|
AU2010212547B2
(en)
|
2009-02-10 |
2015-03-12 |
Seqirus UK Limited |
Influenza vaccine regimens for pandemic-associated strains
|
EP2396031A1
(fr)
|
2009-02-10 |
2011-12-21 |
Novartis AG |
Vaccins contre l'influenza possédant des quantités accrues d'antigène h3
|
AU2010220103A1
(en)
|
2009-03-06 |
2011-09-22 |
Novartis Ag |
Chlamydia antigens
|
EP2228054A1
(fr)
*
|
2009-03-13 |
2010-09-15 |
ITALFARMACO S.p.A. |
Suspensions aqueuses au riluzole
|
JP5668049B2
(ja)
|
2009-03-24 |
2015-02-12 |
ノバルティス アーゲー |
髄膜炎菌h因子結合タンパク質および肺炎球菌糖結合体の組み合わせ
|
MX363222B
(es)
|
2009-04-14 |
2019-03-15 |
Novartis Ag |
Composiciones para inmunizacion contra staphylococcus aureus.
|
NZ596722A
(en)
*
|
2009-05-19 |
2013-08-30 |
Univ Melbourne |
A temperature sensitive vaccine strain of mycoplasma hyopneumoniae and uses thereof
|
PT2401384E
(pt)
|
2009-05-21 |
2012-12-19 |
Novartis Ag |
Genética reversa com recurso a promotores da pol i não endógenos
|
WO2010136896A1
(fr)
|
2009-05-29 |
2010-12-02 |
Novartis Ag |
Dosages d'hémagglutinines de virus de la grippe
|
SG177533A1
(en)
|
2009-07-07 |
2012-02-28 |
Novartis Ag |
Conserved escherichia coli immunogens
|
CN102770443A
(zh)
|
2009-07-16 |
2012-11-07 |
诺华有限公司 |
脱毒大肠杆菌免疫原
|
EP2459708B1
(fr)
*
|
2009-07-31 |
2016-06-22 |
National Research Council of Canada |
Epitope de base externe de h. pylori lipopolysaccharide
|
TWI627281B
(zh)
*
|
2009-09-02 |
2018-06-21 |
百靈佳殷格翰家畜藥品公司 |
降低pcv-2組合物殺病毒活性之方法及具有改良免疫原性之pcv-2組合物
|
WO2011030218A1
(fr)
|
2009-09-10 |
2011-03-17 |
Novartis Ag |
Vaccins combinés contre les maladies des voies respiratoires
|
KR101746880B1
(ko)
*
|
2009-09-10 |
2017-06-14 |
메리얼 인코포레이티드 |
사포닌-함유 면역보강제를 포함하는 신규 백신 제형
|
GB0917002D0
(en)
|
2009-09-28 |
2009-11-11 |
Novartis Vaccines Inst For Global Health Srl |
Improved shigella blebs
|
GB0917003D0
(en)
|
2009-09-28 |
2009-11-11 |
Novartis Vaccines Inst For Global Health Srl |
Purification of bacterial vesicles
|
EP2483390A2
(fr)
|
2009-09-30 |
2012-08-08 |
Novartis AG |
Expression de polypeptides fhbp méningococciques
|
GB0918392D0
(en)
|
2009-10-20 |
2009-12-02 |
Novartis Ag |
Diagnostic and therapeutic methods
|
PL2491117T3
(pl)
|
2009-10-20 |
2014-05-30 |
Novartis Ag |
Udoskonalone sposoby odzyskiwania wirusa wykorzystujące odwrotną genetykę
|
GB0919690D0
(en)
|
2009-11-10 |
2009-12-23 |
Guy S And St Thomas S Nhs Foun |
compositions for immunising against staphylococcus aureus
|
WO2011080595A2
(fr)
|
2009-12-30 |
2011-07-07 |
Novartis Ag |
Immunogènes de polysaccharide conjugués à des protéines porteuses de e. coli
|
GB201003333D0
(en)
|
2010-02-26 |
2010-04-14 |
Novartis Ag |
Immunogenic proteins and compositions
|
MX2012010609A
(es)
|
2010-03-18 |
2012-10-03 |
Novartis Ag |
Vacunas adyuvadas para meningococos serogrupo b.
|
FR2957933B1
(fr)
*
|
2010-03-24 |
2012-04-27 |
Seppic Sa |
Vaccin vivant pour maladies aviaires
|
GB201005625D0
(en)
|
2010-04-01 |
2010-05-19 |
Novartis Ag |
Immunogenic proteins and compositions
|
US9744228B2
(en)
|
2010-04-07 |
2017-08-29 |
Norvartis Ag |
Method for generating a parvovirus B19 virus-like particle
|
JP5815676B2
(ja)
|
2010-04-30 |
2015-11-17 |
テマセック・ライフ・サイエンシズ・ラボラトリー・リミテッド |
H5n1系列に対する汎用ワクチン
|
US20130064852A1
(en)
|
2010-05-11 |
2013-03-14 |
Intervet International B.V. |
Vaccine against mycoplasma, hyopneumoniae, suitable for administration in the presence of maternally derived antibodies
|
JP5876036B2
(ja)
|
2010-05-21 |
2016-03-02 |
ノバルティス アーゲー |
インフルエンザウイルス再集合方法
|
GB201009861D0
(en)
|
2010-06-11 |
2010-07-21 |
Novartis Ag |
OMV vaccines
|
WO2011161653A1
(fr)
|
2010-06-25 |
2011-12-29 |
Novartis Ag |
Associations de protéines de liaison du facteur h méningococcique
|
MX2013000163A
(es)
|
2010-07-06 |
2013-03-05 |
Novartis Ag |
Metodos y composiciones inmunogenicas derivadas de norovirus.
|
GB201017519D0
(en)
|
2010-10-15 |
2010-12-01 |
Novartis Vaccines Inst For Global Health S R L |
Vaccines
|
WO2012072769A1
(fr)
|
2010-12-01 |
2012-06-07 |
Novartis Ag |
Epitopes rrgb de pneumocoque et combinaisons de variantes
|
US20140112950A1
(en)
|
2011-03-02 |
2014-04-24 |
Manmohan Singh |
Combination vaccines with lower doses of antigen and/or adjuvant
|
ES2687129T3
(es)
|
2011-07-25 |
2018-10-23 |
Glaxosmithkline Biologicals Sa |
Composiciones y métodos para evaluar la inmunogenicidad funcional de vacunas contra parvovirus
|
TR201909110T4
(tr)
|
2011-09-14 |
2019-07-22 |
Glaxosmithkline Biologicals Sa |
Sakarit-protein glikokonjugatları yapmaya yönelik yöntemler.
|
JP2014532620A
(ja)
|
2011-10-20 |
2014-12-08 |
ノバルティス アーゲー |
小児の初回免疫のためのアジュバント添加インフルエンザbウイルスワクチン
|
EP3023790A1
(fr)
|
2011-12-12 |
2016-05-25 |
Novartis AG |
Dosage pour hémagglutinines du virus de la grippe
|
US20150044251A1
(en)
|
2011-12-23 |
2015-02-12 |
Novartis Ag |
Stable compositions for immunising against staphylococcus aureus
|
CN104203274B
(zh)
|
2012-02-14 |
2017-09-08 |
梅里亚股份有限公司 |
轮状病毒亚单位疫苗及其制备和使用的方法
|
JP6054883B2
(ja)
|
2012-03-02 |
2016-12-27 |
ノバルティス アーゲー |
インフルエンザウイルスの再集合
|
CA2875752A1
(fr)
|
2012-06-04 |
2013-12-12 |
Novartis Ag |
Test de securite ameliore
|
CN110563818A
(zh)
|
2012-08-31 |
2019-12-13 |
诺华股份有限公司 |
用于针对金黄色葡萄球菌的免疫的稳定化的蛋白质
|
US20150203543A1
(en)
|
2012-08-31 |
2015-07-23 |
Novartis Ag |
Stabilised proteins for immunising against staphylococcus aureus
|
PL2943219T3
(pl)
|
2012-09-10 |
2022-08-22 |
Susan Szathmary |
Szczepionka do zapobiegania zakażeniu mykoplazmalnemu u ptactwa wodnego
|
CA2882382A1
(fr)
|
2012-09-18 |
2014-03-27 |
Novartis Ag |
Vesicules de membrane externe
|
SG11201502197XA
(en)
|
2012-10-02 |
2015-04-29 |
Glaxosmithkline Biolog Sa |
Nonlinear saccharide conjugates
|
GB201218195D0
(en)
|
2012-10-10 |
2012-11-21 |
Istituto Zooprofilattico Sperimentale Delle Venezie |
Composition
|
SG10201706671WA
(en)
|
2012-11-30 |
2017-09-28 |
Glaxosmithkline Biologicals Sa |
Pseudomonas antigens and antigen combinations
|
CN105120893B
(zh)
|
2012-12-03 |
2018-11-13 |
诺华股份有限公司 |
流感病毒重配
|
JP6525469B2
(ja)
|
2013-03-13 |
2019-06-05 |
ノバルティス アーゲー |
インフルエンザb型ウイルス再集合
|
US9649370B2
(en)
|
2013-05-08 |
2017-05-16 |
Protatek International, Inc. |
Vaccine for PCV2 and mycoplasma
|
MX2015015428A
(es)
|
2013-05-10 |
2016-07-18 |
Novartis Ag |
Eliminacion de riesgo de narcolepsia en vacunas contra influenza.
|
DE202013005130U1
(de)
|
2013-06-05 |
2013-09-10 |
Novartis Ag |
Influenza Virus Reassortierung
|
DE202013005100U1
(de)
|
2013-06-05 |
2013-08-26 |
Novartis Ag |
Influenza Virus Reassortierung
|
CN105722976A
(zh)
|
2013-06-06 |
2016-06-29 |
诺华股份有限公司 |
流感病毒重配
|
DK3052516T3
(da)
|
2013-10-02 |
2020-03-23 |
Boehringer Ingelheim Animal Health Usa Inc |
PCV2-ORF2-proteinvariant og viruslignende partikler sammensat deraf
|
US10130698B2
(en)
*
|
2013-12-03 |
2018-11-20 |
Intervet Inc. |
Vaccine against porcine circo virus type 2
|
CN103751779A
(zh)
*
|
2014-02-25 |
2014-04-30 |
中国农业科学院上海兽医研究所 |
O型口蹄疫多肽的泊洛沙姆凝胶佐剂
|
CN106103469B
(zh)
|
2014-03-26 |
2020-11-27 |
葛兰素史密丝克莱恩生物有限公司 |
突变型葡萄球菌抗原
|
US9713639B2
(en)
|
2014-05-19 |
2017-07-25 |
Merial, Inc. |
Recombinant spike protein subunit based vaccine for porcine epidemic diarrhea virus (PEDV)
|
US20150359880A1
(en)
*
|
2014-06-16 |
2015-12-17 |
Biomune Company |
Dual adjuvant vaccine compositions, preparation and uses
|
CN105267963A
(zh)
*
|
2014-06-18 |
2016-01-27 |
潘皓 |
纳米乳疫苗辅剂的制备方法
|
JP2015120709A
(ja)
*
|
2015-01-09 |
2015-07-02 |
ラボラトリオ アヴィメキシコ エスエー ディーイー シーヴィーLaboratorio Avi−Mex,S.A. De C.V. |
遺伝子組み換え不活性化ウィルスベクターワクチン
|
AU2016282761B2
(en)
|
2015-06-26 |
2019-07-04 |
Boehringer Ingelheim Animal Health USA Inc. |
Inactivated canine influenza vaccines and methods of making and uses thereof
|
EP3313439A2
(fr)
|
2015-06-26 |
2018-05-02 |
Seqirus UK Limited |
Vaccins contre la grippe à correspondance antigénique
|
KR20230132628A
(ko)
|
2015-07-07 |
2023-09-15 |
세퀴러스 유케이 리미티드 |
인플루엔자 효능 검정
|
NZ742205A
(en)
|
2015-10-08 |
2019-09-27 |
Vetagro Sup |
Live attenuated heterologous vaccine for leptospira
|
AU2016361305B2
(en)
|
2015-11-23 |
2020-02-06 |
Boehringer Ingelheim Animal Health USA Inc. |
FMDV and E2 fusion proteins and uses thereof
|
TWI760322B
(zh)
|
2016-01-29 |
2022-04-11 |
美商百靈佳殷格翰動物保健美國有限公司 |
重組腺病毒載體裝載之fmdv疫苗及其用途
|
JOP20190088A1
(ar)
|
2016-10-21 |
2019-04-21 |
Us Agriculture |
نواقل مؤتلفة للتعبير عن مولدات مضاد فيروس انفلونزا الطيور و استخداماتها
|
BR112019010394A2
(pt)
*
|
2016-11-29 |
2019-09-03 |
Intervet Int Bv |
vacina suína
|
ES2936117T3
(es)
|
2016-12-14 |
2023-03-14 |
Boehringer Ingelheim Animal Health Usa Inc |
Vectores recombinantes de VHT que expresan múltiples antígenos de patógenos aviares y vacunas que los comprenden
|
FR3092754B1
(fr)
*
|
2019-02-18 |
2022-06-03 |
Total Marketing Services |
Composition adjuvante pour vaccin
|
KR20220128613A
(ko)
|
2019-11-18 |
2022-09-21 |
세퀴러스 피티와이 리미티드 |
재배열 인플루엔자 바이러스의 제조 방법
|
CN113546162B
(zh)
*
|
2021-05-31 |
2023-07-18 |
江苏省农业科学院 |
一种支原体疫苗及其制备方法
|
WO2024133656A1
(fr)
|
2022-12-22 |
2024-06-27 |
Ceva Sante Animale |
Compositions d'adjuvant huileux et émulsions de vaccin comprenant de telles compositions d'adjuvant huileux
|